Jaguar health to present june 21st at medinvest oncology investor conference

Reminder: ladenburg thalmann to host virtual discussion june 22, 2023 at 1:00 pm edt with jaguar ceo and leading patient advocates on impact of cancer therapy-related diarrhea on patients & importance of the patient voice in supportive care; click here to register for event jaguar recently completed patient enrollment in its ongoing pivotal, phase 3 ontarget clinical trial of crofelemer for prophylaxis of diarrhea in adult cancer patients receiving targeted therapy with or without chemotherapy san francisco, ca / accesswire / june 15, 2023 / jaguar health, inc. (nasdaq:jagx) ("jaguar" or the "company") today announced that at 6 p.m. edt on wednesday, june 21, 2023, lisa conte, jaguar's president, founder, and ceo, will present virtually at the medinvest oncology investor conference and will be available to participate in virtual one-on-one meetings during the event.
JAGX Ratings Summary
JAGX Quant Ranking